Why the study?
Does pharmacological therapy reduce the risk of stroke and coronary heart disease in patients with mild to moderate hypertension?
Population
Patients with mild to moderate hypertension
Design
Review
Follow-up
about 3 to 5 years (in discussed trials)
Authors
Loading...
Supports BP lowering in mild-moderate hypertension for stroke prevention; leaves open precise CHD benefits and targets in contemporary practice.
Does pharmacological therapy reduce the risk of stroke and coronary heart disease in patients with mild to moderate hypertension?
Pharmacological therapy for mild to moderate hypertension significantly reduces the risk of stroke, with a smaller but possible reduction in coronary heart disease.
P. R. Hebert (1993) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: